Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients-Reference-Cited by-同舟云学术

Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients

Published:2018-09 Issue:3 Volume:69 Page:603-607
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Agarwal Kosh,Castells Lluís,Müllhaupt Beat,Rosenberg William M.C.,McNabb Brian,Arterburn Sarah,Camus Gregory,McNally John,Stamm Luisa M.,Brainard Diana M.,Mani Subramanian G.,Mariño Zoe,Dufour Jean-François,Forns Xavier

Funder

Gilead Sciences, Inc

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Recurrent and acquired hepatitis C viral infection in liver transplant recipients;Wright;Gastroenterology,1992

2. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes;Prieto;Hepatology,1999

3. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

4. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation;Blasco;Hepatology,2006

5. Viral hepatitis in liver transplantation;Crespo;Gastroenterology,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

2. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

3. Transplantation Pathology;MacSween's Pathology of the Liver;2024

4. Sofosbuvir más glecaprevir/pibrentasvir como terapia de rescate postrasplante hepático en pacientes con exposición previa a inhibidores de NS5A. Serie de casos;Gaceta Médica de México;2023-09-21

5. Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients;Viruses;2023-08-07